Charles Conway
2018
In 2018, Charles Conway earned a total compensation of $2.8M as Chief Scientific Officer at Biohaven Pharmaceutical Holding Co Ltd., a 72% increase compared to previous year.
Compensation breakdown
| Bonus | $205,163 |
|---|---|
| Option Awards | $2,243,800 |
| Salary | $334,960 |
| Other | $8,932 |
| Total | $2,792,855 |
Conway received $2.2M in option awards, accounting for 80% of the total pay in 2018.
Conway also received $205.2K in bonus, $335K in salary and $8.9K in other compensation.
Rankings
In 2018, Charles Conway's compensation ranked 4,171st out of 14,244 executives tracked by ExecPay. In other words, Conway earned more than 70.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,171 out of 14,244 | 71st |
Division Manufacturing | 1,538 out of 5,758 | 73rd |
Major group Chemicals And Allied Products | 550 out of 2,119 | 74th |
Industry group Drugs | 460 out of 1,808 | 75th |
Industry Pharmaceutical Preparations | 356 out of 1,382 | 74th |
Source: SEC filing on April 11, 2019.
Conway's colleagues
We found four more compensation records of executives who worked with Charles Conway at Biohaven Pharmaceutical Holding Co Ltd. in 2018.
2018
Vlad Coric
Biohaven Pharmaceutical Holding Co Ltd.
Chief Executive Officer
2018
James Engelhart
Biohaven Pharmaceutical Holding Co Ltd.
Chief Financial Officer
2018
Kimberly Gentile
Biohaven Pharmaceutical Holding Co Ltd.
SVP, Clinical Operations
2018
John Tilton
Biohaven Pharmaceutical Holding Co Ltd.